Publication: 1056

Impact of c-MYC Protein Expression on Outcome of Patients with Early-Stage HER2+ Breast Cancer Treated with Adjuvant Trastuzumab NCCTG (Alliance) N9831
      QxMD      Google Scholar   
Citation:
Clin Cancer Res vol 19 (20) 5798-5807
Year:
2013
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
Yes
Book Volume:
3
Parents:
536   661  
Children:
None
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
 
Grants:
U24 CA114740, CA114740, P30 CA015083, R01 CA129949, CA129949, U10 CA025224, CA25224-31  
Corr. Author:
 
Authors:
                                       
Networks:
 
Study
NCCTG-N9831
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords:
trastuzumab, HER2-positive, breast cancer, MYC protein expression, disease-free survival